Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Protection certificate |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 12 2021 000 066.6 |
| Use | VZ | Medicinal products |
95 | Product name | TIEZ | Tirbanibulin |
54 | Title of basic patent | TIGZ | ZUSAMMENSETZUNGEN UND VERFAHREN FÜR DIE BEHANDLUNG VON ZELLPROLIFERATIONSERKRANKUNGEN |
51 | IPC main class | ICM (ICMV) | C07D 213/56 (2006.01) |
94 | Start of term of protection | LB | Dec 29, 2025 |
94 | End of term of protection | LE | Dec 28, 2030 |
22 | DE application date | DAT | Oct 20, 2021 |
| Date of publication of application for a certificate | OT | Jan 5, 2022 |
| Date of publication of grant of certificate | PET | Jan 2, 2025 |
71/73 | Applicant/owner | INH | ATNX SPV, LLC, 1001 Main Street, 14203 Buffalo, NY, US |
74 | Representative | VTR | König Szynka Tilmann von Renesse Patentanwälte Partnerschaft mbB, 40545 Düsseldorf, DE |
| Address for service | | König Szynka Tilmann von Renesse Patentanwälte Partnerschaft mbB, 40545 Düsseldorf, DE |
| Due date | FT FG | Dec 31, 2025 Annual fee for the 21st year
Patent fees |
| Patent division in charge | | 44 |
68 | DE file number of basic patent | GAKZ | 60 2005 032 638.3 |
68 | EP file number of basic patent | GEAKZ | 05 85 5828.9 |
43 | Date of first publication | EVT | Jan 5, 2022 |
92 92 92
| Domestic authorisation | GIS GIN GIT
| Europäische Kommission EU/1/21/1558 2021-07-16
|
93 93 93 93
| EU authorisation | GES GEC GEN GET
| Europäische Kommission EU EU/1/21/1558 2021-07-16
|
| Date of the first transfer into DPMAregister | EREGT | Jan 5, 2022 |
| Date of the (most recent) update in DPMAregister | REGT | Jan 2, 2025 (Show all update days)(Hide all update days)- Jan 2, 2025
- Date of publication of grant of certificate: new
- Procedures: Supplementary protection certificate procedure, Certificate granted, 29.10.2024: changed
- Nov 27, 2024
- Procedures: Supplementary protection certificate procedure, Certificate granted, 29.10.2024: new
- Sep 21, 2024
- Product name: changed
- End of term of protection: new
- Due date: new
- Procedures: Supplementary protection certificate procedure, Decision to grant certificate by Patent Division, 20.09.2024: new
- Aug 12, 2024
- St.36: changed (technical change)
- Aug 24, 2023; Aug 18, 2023; Jul 18, 2023; Mar 6, 2023
- Historical data not available for this/these date(s)
- Jan 5, 2022
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 2)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Dec 22, 2021 |
71/73 | Applicant/owner | INH | Athenex, Inc. (n. d. Ges. d. Staates Delaware), Buffalo, N.Y., US |
71/73 | Previous applicant/owner | INHF | Kinex Pharmaceuticals, LLC., 14203 Buffalo, NY, US |
| Date of update of the procedure | REGT | Jan 5, 2022 |
View procedures New applicant/owner details (No.: 3)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Mar 3, 2023 |
71/73 | Applicant/owner | INH | ATNX SPV, LLC, 14203 Buffalo, NY, US |
71/73 | Previous applicant/owner | INHF | Athenex, Inc. (n. d. Ges. d. Staates Delaware), Buffalo, N.Y., US |
| Date of update of the procedure | REGT | Mar 6, 2023 |